The University of Alabama at Birmingham launched the MyLupus app to inform patients about their disease and symptoms and assist them when working with medical professionals. The free app is the latest ...
The FDA approved a 200 mg/mL belimumab autoinjector for pediatric lupus nephritis, enabling at-home administration and reducing clinic visits. Lupus nephritis affects 30-50% of children with SLE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results